3,4-DIHYDRO-2H-PYRIDO[4,3-B][1,4]OXAZINE, 95.0%, 500mg

Dicyclopentyldimethoxysilane, 95.0%, 100g

2-(1-Methylpiperidin-4-yl)ethanamine, 95.0%, 250mg

(R)-1-Boc-3-Hydroxymethylpyrrolidine, 95.0%, 10g

5-Acenaphthylmagnesium bromide 0.5 M in Tetrahydrofuran, 50ml

(2S,4S)-1-(tert-Butoxycarbonyl)-4-(difluoromethyl)pyrrolidine-2-carboxylic acid, 95.0%, 100mg

Planifiez un objectif PLPOLi 100x/0,80 IOS sans stress pour la polarisation incidente iScope, sans correction du verre de couverture. Distance de travail 2 mm

(S)-8-(Benzyloxy)-7-methoxy-10-((2-(trimethylsilyl)ethoxy)methyl)-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-2,5,11(3H,10H,11aH)-trione, 250mg

4-Bromo-2-chlorobenzotrifluoride>98.0%(GC)5g

2-(4-BROMOPHENYL)-3,6-DIHYDRO-2H-PYRAN, 95.0%, 250mg

2-(4-bromophenyl)-5,6-dihydro-4H-1,3,4-oxadiazin-5-one, 95.0%, 1g

Diethyl (4-(5-oxido-10H-phenothiazin-10-yl)butyl)phosphonate, 97%, 1g

7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 100mg